Dermal Microcoring for Skin Laxity, Rhytides, and Scars.

IF 2.5 3区医学 Q2 DERMATOLOGY Dermatologic Surgery Pub Date : 2024-11-01 DOI:10.1097/DSS.0000000000004432

David A Hashemi, Joy Tao, Jordan V Wang, Girish Munavalli, Roy G Geronemus

{"title":"Dermal Microcoring for Skin Laxity, Rhytides, and Scars.","authors":"David A Hashemi, Joy Tao, Jordan V Wang, Girish Munavalli, Roy G Geronemus","doi":"10.1097/DSS.0000000000004432","DOIUrl":null,"url":null,"abstract":"Background: Dermal microcoring extracts cores of skin that are small enough to allow healing in a scarless fashion. Its use has been reported in the treatment of skin laxity, rhytides, and textural abnormalities.Objective: To report the authors' clinical experience using dermal microcoring in a variety of cases.Materials and methods: A retrospective chart review was performed looking at dermal microcoring cases for any indication between August 2022 and March 2024.Results: Thirty-eight patients were treated. Overall, 32 (84.2%) patients were women, with median age of 67 years (R: 20-80 years). Fitzpatrick skin types I to V were represented. Among patients with adequate photographs for review, improvements of grade 3 and 4 (good and excellent) were seen in 85.7% (n = 18/21) treated for skin laxity and rhytides, 50.0% (n = 3/6) treated for acne scars, 66.7% (n = 2/3) treated for traumatic or surgical scars, and 100.0% (n = 3/3) treated for foreign material. Six (15.4%) patients experienced erythema or hyperpigmentation lasting more than 4 weeks, and 2 (5.1%) patients experienced temporary focal scarring, which improved with intralesional therapy and laser treatment. No patients experienced permanent dyspigmentation, prolonged edema, or infection.Conclusion: Dermal microcoring has been demonstrated to safely and effectively treat skin laxity, rhytides, scars, and foreign material.","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":"50 11S","pages":"S135-S138"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556863/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatologic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/DSS.0000000000004432","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Dermal microcoring extracts cores of skin that are small enough to allow healing in a scarless fashion. Its use has been reported in the treatment of skin laxity, rhytides, and textural abnormalities.

Objective: To report the authors' clinical experience using dermal microcoring in a variety of cases.

Materials and methods: A retrospective chart review was performed looking at dermal microcoring cases for any indication between August 2022 and March 2024.

Results: Thirty-eight patients were treated. Overall, 32 (84.2%) patients were women, with median age of 67 years (R: 20-80 years). Fitzpatrick skin types I to V were represented. Among patients with adequate photographs for review, improvements of grade 3 and 4 (good and excellent) were seen in 85.7% (n = 18/21) treated for skin laxity and rhytides, 50.0% (n = 3/6) treated for acne scars, 66.7% (n = 2/3) treated for traumatic or surgical scars, and 100.0% (n = 3/3) treated for foreign material. Six (15.4%) patients experienced erythema or hyperpigmentation lasting more than 4 weeks, and 2 (5.1%) patients experienced temporary focal scarring, which improved with intralesional therapy and laser treatment. No patients experienced permanent dyspigmentation, prolonged edema, or infection.

Conclusion: Dermal microcoring has been demonstrated to safely and effectively treat skin laxity, rhytides, scars, and foreign material.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

针对皮肤松弛、褶皱和疤痕的皮肤微切术

背景：真皮微切口提取的皮肤核心足够小，可以在无疤痕的情况下愈合。据报道，它可用于治疗皮肤松弛、褶皱和纹理异常：报告作者在各种病例中使用真皮微切口的临床经验：对 2022 年 8 月至 2024 年 3 月期间任何适应症的真皮微切病例进行回顾性病历审查：结果：共有 38 名患者接受了治疗。总体而言，32 名（84.2%）患者为女性，中位年龄为 67 岁（R：20-80 岁）。菲茨帕特里克皮肤类型为 I 至 V。在有足够照片供复查的患者中，85.7%（18/21）的皮肤松弛和褶皱患者、50.0%（3/6）的痤疮疤痕患者、66.7%（2/3）的外伤或手术疤痕患者以及100.0%（3/3）的异物疤痕患者的治疗效果达到了3级和4级（良好和极佳）。有 6 名患者（15.4%）出现了持续 4 周以上的红斑或色素沉着，2 名患者（5.1%）出现了暂时性局灶性疤痕，但经过点内治疗和激光治疗后情况有所改善。没有患者出现永久性色素沉着、长期水肿或感染：结论：皮肤微切口已被证明能安全有效地治疗皮肤松弛、皱褶、疤痕和异物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Dermatologic Surgery 医学-皮肤病学

CiteScore

3.10

自引率

16.70%

发文量

547

期刊介绍： Exclusively devoted to dermatologic surgery, the Dermatologic Surgery journal publishes the most clinically comprehensive and up-to-date information in its field. This unique monthly journal provides today’s most expansive and in-depth coverage of cosmetic and reconstructive skin surgery and skin cancer through peer-reviewed original articles, extensive illustrations, case reports, ongoing features, literature reviews and correspondence. The journal provides information on the latest scientific information for all types of dermatologic surgery including: -Ambulatory phlebectomy- Blepharoplasty- Body contouring- Chemical peels- Cryosurgery- Curettage and desiccation- Dermabrasion- Excision and closure- Flap Surgery- Grafting- Hair restoration surgery- Injectable neuromodulators- Laser surgery- Liposuction- Microdermabrasion- Microlipoinjection- Micropigmentation- Mohs micrographic surgery- Nail surgery- Phlebology- Sclerotherapy- Skin cancer surgery- Skin resurfacing- Soft-tissue fillers. Dermatologists, dermatologic surgeons, plastic surgeons, oculoplastic surgeons and facial plastic surgeons consider this a must-read publication for anyone in the field.